Integral Molecular Named a Top Workplace by Philadelphia Inquirer

PHILADELPHIA, May 21, 2025 /PRNewswire/ -- Integral Molecular, a founding member of Philadelphia's biotechnology hub, has been recognized as a 2025 Top Workplace by the Philadelphia Inquirer. This honor is based entirely on employee feedback and benchmarking against national standards, gathered through a confidential survey.

See the full list of Top Workplaces named by the Philadelphia Inquirer

"We are honored to be recognized as a 2025 Top Workplace in Philadelphia," said Sharon Willis, PhD, Co-founder of Integral Molecular. "This award reflects the collaborative and mission-driven culture we have built together, where people are supported to thrive in their career. Our company's growth is based on continuing to hire remarkable people."

Integral Molecular's success is rooted in its commitment to people and its supportive culture.

• Employee Development and a People First Culture: A supportive work environment where individual and team accomplishments are celebrated.
• Community Partnerships: Strong connections with local organizations for recruiting, training, and retaining homegrown talent.
• Biotechnology Leadership: Active participation in regional initiatives such as the Keystone Life Sciences Collaborative, promoting the expansion of the Pennsylvania life sciences ecosystem.

This recognition follows a year of notable achievements for the company. Integral Molecular was also named an Employer of Choice by the City of Philadelphia, and CEO Benjamin Doranz was honored as CEO of the Year by Life Sciences PA. Integral Molecular continues to grow, with multiple positions open.

Learn more about Integral Molecular and view open positions

About Integral Molecular

Integral Molecular (integralmolecular.com) is the industry leader in creating transformative technologies that advance the discovery of therapeutics against difficult protein targets. With 20+ years of experience focused on antibodies, membrane proteins, and viruses, Integral Molecular's technologies have been integrated into the drug discovery pipelines of over 600 biotech and pharmaceutical companies to help discover new therapies for cancer, diabetes, autoimmune disorders, and viral threats such as SARS-CoV-2, Ebola, Zika, and dengue viruses.

Follow Integral Molecular on LinkedIn

Press Contact
Integral Molecular
Soma Banik, PhD, Director of Public Relations
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/integral-molecular-named-a-top-workplace-by-philadelphia-inquirer-302461054.html

SOURCE Integral Molecular